SCHEMBL1576747

SCHEMBL1576747

C=C(C)COCCCCO

nearest known ligand 0.39

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
CES2 O00748 2/20 0.39
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
THRB P10828 1/20 0.37
HTT P42858 1/20 0.37
MAPT P10636 1/20 0.37
TSHR P16473 2/20 0.36
GAA P10253 1/20 0.34
CYP4F2 P78329 1/20 0.34
CYP4A11 Q02928 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.32
LMNA P02545 2/20 0.31
ALDH1A1 P00352 1/20 0.31
HSD17B10 Q99714 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8537833 0.98 MEN1 (0.40) CES2MEN1KMT2ATHRBHTT
SCHEMBL8533909 0.98 MEN1 (0.40) CES2MEN1KMT2ATHRBHTT
SCHEMBL2793665 0.98 CES2 (0.42) CES2MEN1KMT2ATHRBHTT
SCHEMBL2790873 0.98 CES2 (0.42) CES2MEN1KMT2ATHRBHTT
SCHEMBL1576797 0.93
SCHEMBL871697 0.90 CES2 (0.44) CES2MEN1KMT2ATHRBHTT
SCHEMBL10031351 0.88 MEN1 (0.40) CES2MEN1KMT2ATHRBHTT
1,4-Butanediol SCHEMBL871698 0.87 SMN1; SMN2 (0.36) MEN1KMT2ATSHRSMN1; SMN2LMNA
SCHEMBL7256155 0.85 CES2 (0.39) CES2TSHRHSD17B10
SCHEMBL1326296 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100510183-C Aqueous surface treatment agent for plated metal sheet, surface-treated metal sheet, and method for producing same NIPPON STEEL CORP NIHON PARKER (JP) 2009-07-08 CN claimed
US-20260028282-A1 ALUMINOSILICATE-CONTAINING COMPOSITION NIPPON CATALYTIC CHEM IND (JP) 2026-01-29 US disclosed
EP-4678615-A1 ALUMINOSILICATE-CONTAINING COMPOSITION Nippon Shokubai Co., Ltd. (JP) 2026-01-14 EP disclosed
US-20250162943-A1 CEMENTITIOUS CEMENT-BASED HYDRAULIC MATERIAL OBAYASHI CORPORATION (JP) 2025-05-22 US disclosed
WO-2024242009-A1 ALUMINOSILICATE-CONTAINING COMPOSITION 株式会社日本触媒 2024-11-28 WO disclosed
WO-2023182439-A1 CEMENT-BASED HYDRAULIC-SETTING MATERIAL 株式会社大林組 2023-09-28 WO disclosed
US-8735534-B2 Precursor composition for polyimide and use thereof ETERNAL CHEMICAL CO., LTD. (TW) 2014-05-27 US disclosed
US-20130090432-A1 ALKOXYLATED POLYMERS BASF SE (DE) 2013-04-11 US disclosed
EP-2483320-A1 ALKOXYLATED POLYMERS BASF SE (DE) 2012-08-08 EP disclosed
CN-102549033-A Alkoxylated polymers BASF SE 2012-07-04 CN disclosed
EP-1601627-A1 CEMENT ADMIXTURE, CEMENT COMPOSITION AND METHOD FOR LAYING WORK THE SAME, AND METHOD FOR PRODUCING CEMENT HARDENED PRODUCT Nippon Shokubai Co., Ltd. (JP) 2005-12-07 EP disclosed
WO-2004089845-A1 CEMENT ADMIXTURE AND CEMENT COMPOSITION NIPPON SHOKUBAI CO., LTD. (JP) 2004-10-21 WO disclosed
WO-2004078672-A1 CEMENT ADMIXTURE, CEMENT COMPOSITION AND METHOD FOR LAYING WORK THE SAME, AND METHOD FOR PRODUCING CEMENT HARDENED PRODUCT NIPPON SHOKUBAI CO., LTD. (JP) 2004-09-16 WO disclosed
EP-1390317-A1 CEMENT ADMIXTURE AND CEMENT COMPOSITION Nippon Shokubai Co., Ltd. (JP) 2004-02-25 EP disclosed
CN-1463259-A Cement admixture and cement composition NIPPON CATALYTIC CHEM IND (JP) 2003-12-24 CN disclosed
WO-2002096823-A1 CEMENT ADMIXTURE AND CEMENT COMPOSITION NIPPON SHOKUBAI CO., LTD. (JP) 2002-12-05 WO disclosed
EP-0819693-B1 Cyclic silane esters and their solvolysis products and process for preparing same DEGUSSA (DE) 2002-11-13 EP disclosed
EP-0953601-A1 AQUEOUS EMULSION CONTAINING FINE PARTICLES OF CROSS-LINKED ALLYLIC COPOLYMER DAISO CO., LTD. (JP) 1999-11-03 EP disclosed
US-5786493-A SILYNATION OF UNSATURATED ALCOHOL, CYCLIZATION AND SOLVOLYSIS HUELS AKTIENGESELLSCHAFT (DE) 1998-07-28 US disclosed
EP-0819693-A2 Cyclic silane esters and their solvolysis products and process for preparing same HÜLS AKTIENGESELLSCHAFT (DE) 1998-01-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260028282-A1 ALUMINOSILICATE-CONTAINING COMPOSITION ASH2L, CACNA2D2, CACNA2D1 CES2 4269/4885MEN1 1264/4885KMT2A 986/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.